← All companies

HRMY

Harmony Biosciences Holdings, Inc.

HRMY Nasdaq Pharmaceutical Preparations EDGAR ↗

$35.60

-0.26 -0.72%

Key statistics

from XBRL data in SEC filings

Market cap

$2.06B

Revenue (TTM)

$899M

Net income (TTM)

$146M

EPS (TTM)

$2.48

P/E ratio

14.4

Dividend yield

—

Free cash flow

$348M

Cash

$589M

Total assets

$1.27B

Gross margin

76.5%

52-week range

$25.52 – $40.87

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jul 16, 2026 8-K Shareholder vote results May 14, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change; Regulation FD disclosure Apr 14, 2026 8-K Director or officer change; Regulation FD disclosure Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 24, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Results of operations (earnings release) Oct 23, 2025 8-K Regulation FD disclosure Sep 24, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2025 8-K Regulation FD disclosure Jun 11, 2025 8-K Other events Jun 5, 2025 8-K Shareholder vote results May 15, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2025 8-K Director or officer change; Regulation FD disclosure Apr 3, 2025 8-K Director or officer change; Other events Mar 24, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 25, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 8-K Other events Nov 1, 2024 10-Q Quarter ended 2024-09-30 Oct 29, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Oct 29, 2024 8-K Regulation FD disclosure Oct 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 6, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Director or officer change; Other events Jul 1, 2024 8-K Shareholder vote results May 29, 2024 8-K Director or officer change May 3, 2024 10-Q Quarter ended 2024-03-31 Apr 30, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2024 8-K Entered a material agreement; Other events Apr 11, 2024 10-K/A Fiscal year ended 2023-12-31 Feb 28, 2024 10-K Fiscal year ended 2023-12-31 Feb 22, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 22, 2024